Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 857642, 7 pages
http://dx.doi.org/10.1155/2015/857642
Clinical Study

Magnetic Resonance Comparison of Left-Right Heart Volumetric and Functional Parameters in Thalassemia Major and Thalassemia Intermedia Patients

1Department of Radiology, A.O.R.N. Cardarelli, Via Antonio Cardarelli 9, 80100 Naples, Italy
2Department of Diagnostic Imaging, Campus Bio-Medico University, Via Alvaro del Portillo 200, 00128 Rome, Italy
3Unit of Measurements and Biomedical Instrumentation, Campus Bio-Medico University, Via Alvaro del Portillo 200, 00128 Rome, Italy
4Department of Hematology, Sant’Eugenio Hospital, Piazzale dell’Umanesimo 10, 00143 Rome, Italy

Received 10 December 2014; Revised 4 March 2015; Accepted 6 March 2015

Academic Editor: Cristiana Corsi

Copyright © 2015 Carlo Liguori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. T. Taher, K. M. Musallam, M. D. Cappellini, and D. J. Weatherall, “Optimal management of β thalassaemia intermedia,” British Journal of Haematology, vol. 152, no. 5, pp. 512–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Weatherall and J. B. Clegg, The Thalssemias Syndromes, Blackwell Science, Oxford, UK, 2011.
  3. M. G. Zurlo, P. de Stefano, C. Borgna-Pignatti et al., “Survival and causes of death in thalassaemia major,” The Lancet, vol. 2, no. 8653, pp. 27–30, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Modell and V. Berdoukas, The Clinical Approach to Thalassemia, Grune & Stratton, New York, NY, USA, 1984.
  5. E. P. Vichinsky, “Pulmonary hypertension in sickle cell disease,” The New England Journal of Medicine, vol. 350, no. 9, pp. 857–859, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Aessopos, D. Farmakis, and D. Loukopoulos, “Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes,” Blood, vol. 99, no. 1, pp. 30–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Aessopos, M. Kati, and D. Farmakis, “Heart disease in thalassemia intermedia: a review of the underlying pathophysiology,” Haematologica, vol. 92, no. 5, pp. 658–665, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kirk, M. Roughton, J. B. Porter et al., “Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia Major,” Circulation, vol. 120, no. 20, pp. 1961–1968, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. A. Bluemke and R. P. Liddell, “Science to practice: can MR imaging provide a noninvasive ‘biopsy’ of the heart to measure iron levels?” Radiology, vol. 234, no. 3, pp. 647–648, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Wood, “Diagnosis and management of transfusion iron overload: the role of imaging,” The American Journal of Hematology, vol. 82, no. 12, pp. 1132–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Aessopos, D. Farmakis, M. Karagiorga et al., “Cardiac involvement in thalassemia intermedia: a multicenter study,” Blood, vol. 97, no. 11, pp. 3411–3416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Modell, M. Khan, M. Darlison, M. A. Westwood, D. Ingram, and D. J. Pennell, “Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance,” Journal of Cardiovascular Magnetic Resonance, vol. 10, no. 1, article 42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. J. Anderson, S. Holden, B. Davis et al., “Cardiovascular T2-star (T2) magnetic resonance for the early diagnosis of myocardial iron overload,” European Heart Journal, vol. 22, no. 23, pp. 2171–2179, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Pepe, V. Positano, M. F. Santarelli et al., “Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload,” Journal of Magnetic Resonance Imaging, vol. 23, no. 5, pp. 662–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Meloni, V. Positano, A. Pepe et al., “Preferential patterns of myocardial iron overload by multislice multiecho T2* CMR in thalassemia major patients,” Magnetic Resonance in Medicine, vol. 64, no. 1, pp. 211–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. A. McKee, W. P. Castelli, P. M. McNamara, and W. B. Kannel, “The natural history of congestive heart failure: the Framingham Study,” The New England Journal of Medicine, vol. 285, no. 26, pp. 1441–1446, 1971. View at Publisher · View at Google Scholar · View at Scopus
  17. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 37, pp. S81–S90, 2014. View at Google Scholar
  18. R. D. Mosteller, “Simplified calculation of body-surface area,” The New England Journal of Medicine, vol. 317, article 1098, 1987. View at Google Scholar · View at Scopus
  19. M. Marsella, C. Borgna-Pignatti, A. Meloni et al., “Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study,” Haematologica, vol. 96, no. 4, pp. 515–520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Hershko, G. Link, and I. Cabantchik, “Pathophysiology of iron overload,” Annals of the New York Academy of Sciences, vol. 850, pp. 191–201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Wood, C. Enriquez, N. Chugre et al., “Physiology and pathophysiology of iron cardiomyphaty in thalassemia,” Annals of the New York Academy of Sciences, vol. 1054, pp. 386–395, 2005. View at Google Scholar
  22. D. J. Pennell, “T2 magnetic resonance and myocardial iron in thalassemia,” Annals of the New York Academy of Sciences, vol. 1054, pp. 373–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-P. Carpenter, F. Alpendurada, M. Deac et al., “Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload,” Journal of Cardiovascular Magnetic Resonance, vol. 12, no. 1, article 24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Westwood, L. J. Anderson, A. M. Maceira et al., “Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron,” Journal of Magnetic Resonance Imaging, vol. 25, no. 6, pp. 1147–1151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Tanner, R. Galanello, C. Dessi et al., “Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction,” Journal of Cardiovascular Magnetic Resonance, vol. 10, article 12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. L. J. Anderson, M. A. Westwood, S. Holden et al., “Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance,” British Journal of Haematology, vol. 127, no. 3, pp. 348–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Alpendurada, J.-P. Carpenter, M. Deac et al., “Relation of myocardial T2* to right ventricular function in thalassaemia major,” European Heart Journal, vol. 31, no. 13, pp. 1648–1654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Aessopos, S. Deftereos, D. Farmakis et al., “Cardiovascular adaptation to chronic anemia in the elderly: an echocardiographic study,” Clinical and Investigative Medicine, vol. 27, no. 5, pp. 265–273, 2004. View at Google Scholar · View at Scopus
  29. R. Galanello, S. Barella, M. P. Turco et al., “Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin β-thalassemia intermedia patients,” Blood, vol. 83, no. 2, pp. 561–565, 1994. View at Google Scholar · View at Scopus